- Home
- NVST
as 07-08-2024 1:36pm EST
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | BREA |
| Market Cap: | 3.1B | IPO Year: | 2019 |
| Target Price: | $24.88 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Hold | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $15.92 - $36.14 | Next Earning Date: | 07-31-2024 |
| Revenue: | $2,562,900,000 | Revenue Growth: | -0.08% |
| Revenue Growth (this year): | 2.08% | Revenue Growth (next year): | 3.59% |
Stock Insider Trading Activity of Envista Holdings Corporation (NVST)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nance Mark E | NVST | General Counsel | Nov 8 '23 | Buy | $21.75 | 5,000 | $108,750.00 | 39,042 | SEC Form 4 |
| Aghdaei Amir | NVST | Chief Executive Officer | Nov 6 '23 | Buy | $21.53 | 7,802 | $167,977.06 | 293,164 | SEC Form 4 |
| Aghdaei Amir | NVST | Chief Executive Officer | Nov 6 '23 | Buy | $21.52 | 600 | $12,912.00 | 293,764 | SEC Form 4 |
| Aghdaei Amir | NVST | Chief Executive Officer | Nov 6 '23 | Buy | $21.51 | 701 | $15,078.51 | 294,465 | SEC Form 4 |
| Aghdaei Amir | NVST | Chief Executive Officer | Nov 6 '23 | Buy | $21.50 | 897 | $19,285.50 | 295,362 | SEC Form 4 |
| Keller Stephen | NVST | Principal Financial Officer | Nov 6 '23 | Buy | $21.53 | 2,000 | $43,060.00 | 13,070 | SEC Form 4 |
Latest Envista Holdings Corporation News
NVST Breaking Stock News: Dive into NVST Ticker-Specific Updates for Smart Investing
MedTech Dive
17 days ago
Tandem names Jean-Claude Kyrillos as chief operating officer
MT Newswires
18 days ago
Tandem Diabetes Care Names Jean-Claude Kyrillos COO
Insider Monkey
a month ago
Does Envista Holdings Corp. (NVST) have Opportunities to Drive Upside Over the Long Term?
PR Newswire
a month ago
Envista Smile Project Seeks to Advance Oral Care for Underserved Communities Through $2.1 Million Donation to the University of Southern California's Herman Ostrow School of Dentistry
Zacks
a month ago
Envista (NVST) Down 4.7% Since Last Earnings Report: Can It Rebound?
PR Newswire
2 months ago
Envista Announces Participation in Stifel Jaws & Paws Conference
Simply Wall St.
2 months ago
Envista Holdings Corporation Just Missed Earnings - But Analysts Have Updated Their Models
Simply Wall St.
2 months ago
Is Envista Holdings Corporation (NYSE:NVST) Trading At A 36% Discount?
Share on Social Networks:
Disclaimer
The information presented on this page, "NVST Envista Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.